Pages that link to "Q48026669"

The following pages link to The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse model. (Q48026669):

Displaying 29 items.

• The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity (Q24672570) (← links)
• Comparative gene expression profiling in two congenic mouse strains following Bordetella pertussis infection. (Q33302556) (← links)
• The role of Toll-like receptor-4 in pertussis vaccine-induced immunity (Q33337196) (← links)
• Inefficient Toll-like receptor-4 stimulation enables Bordetella parapertussis to avoid host immunity (Q33402920) (← links)
• Bordetella pertussis infection or vaccination substantially protects mice against B. bronchiseptica infection (Q33496734) (← links)
• O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies (Q33502706) (← links)
• Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection (Q33553221) (← links)
• Genetic control of Bordetella pertussis infection: identification of susceptibility loci using recombinant congenic strains of mice (Q33796054) (← links)
• Role of antibodies against Bordetella pertussis virulence factors in adherence of Bordetella pertussis and Bordetella parapertussis to human bronchial epithelial cells. (Q34000504) (← links)
• Immunoglobulin A-mediated protection against Bordetella pertussis infection (Q34008531) (← links)
• Imperfect vaccine-induced immunity and whooping cough transmission to infants (Q34380525) (← links)
• Role of systemic and mucosal immune responses in reciprocal protection against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection (Q34581910) (← links)
• Host genetics of Bordetella pertussis infection in mice: significance of Toll-like receptor 4 in genetic susceptibility and pathobiology. (Q34601854) (← links)
• Lung response to Bordetella pertussis infection in mice identified by gene-expression profiling (Q35881038) (← links)
• Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice (Q35946895) (← links)
• Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production (Q36404631) (← links)
• Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection (Q39510709) (← links)
• Supplementation of whole-cell pertussis vaccines with lipopolysaccharide analogs: modification of vaccine-induced immune responses (Q40022559) (← links)
• A recombinant iron transport protein from Bordetella pertussis confers protection against Bordetella parapertussis (Q40073161) (← links)
• The O antigen is a critical antigen for the development of a protective immune response to Bordetella parapertussis (Q42613134) (← links)
• Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunity (Q43013370) (← links)
• Inactivated whole-cell bacterial vaccines: current status and novel strategies (Q47611164) (← links)
• Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model (Q47664453) (← links)
• Impaired long-term maintenance and function of Bordetella pertussis specific B cell memory. (Q51044704) (← links)
• Of mice and men: asymmetric interactions between Bordetella pathogen species. (Q51893713) (← links)
• Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis. (Q53477986) (← links)
• Association of Bordetella pertussis with host immune cells in the mouse lung (Q64449427) (← links)
• Lung pathology and immediate hypersensitivity in a mouse model after vaccination with pertussis vaccines and challenge with Bordetella pertussis (Q79561519) (← links)
• Effectiveness of the whole-cell pertussis vaccine produced in Poland against different Bordetella parapertussis isolates in the mouse intranasal challenge model (Q84276331) (← links)